Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase

NCT01802450 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Chronic Myeloid Leukemia

Interventions

DRUG: Dasatinib

Sponsor

PETHEMA Foundation

Collaborators

[object Object]
[object Object]